Browse diseases

…b has expanded the therapeutic landscape for moderate-to-severe ulcerative colitis (UC), with efficacy demonstrated in the LUCENT phase 3 programm…

…d with UC remission and spatial distribution of CD8+ T cells in colorectal cancer. Interestingly, macrophage PKM2 deletion greatly suppressed tum…

…referral. Family history was significant for colonic polyps and ulcerative colitis, though no genetic mutation had been established in relatives.…

…nically significant. We present a case of a man in his 20s with ulcerative colitis and primary sclerosing cholangitis (PSC), who developed exertio…

…P. excrementihominis), a Betaproteobacteria species enriched in ulcerative colitis (UC) patients, is implicated in chronic inflammation. However, …

…Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, requires consistent high-quality care to reduce variation in p…

…m of the IL-23p19 subunit has demonstrated clinical efficacy in inflammatory bowel disease, but the molecular changes underlying the efficacy outcomes hav…

… Importance Inflammatory bowel disease (IBD), which encompasses ulcerative colitis and Crohn’s disease, is a chronic disorder of the gastrointesti…

…sis (PsO), psoriatic arthritis (PsA), Crohn’s disease (CD), and ulcerative colitis (UC).To evaluate treatment in a real-world setting, drug persis…

…ation of risankizumab and other biologic drugs in patients with refractory inflammatory bowel disease, evaluating its clinical efficacy, progression, and safety prof…

… and ustekinumab (UST) in patients with Crohn’s disease (CD) or Ulcerative colitis (UC), and to assess the acceptance of the pharmaceutical recomm…

…Background and Importance Ulcerative colitis (UC) can be treated with Janus kinase inhibitors (JAKi) when co…